These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17109566)

  • 1. Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly.
    Porsteinsson AP
    Drugs Aging; 2006; 23(11):877-86. PubMed ID: 17109566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia.
    Meinhold JM; Blake LM; Mini LJ; Welge JA; Schwiers M; Hughes A
    Drugs Aging; 2005; 22(7):615-26. PubMed ID: 16038575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex sodium therapy in elderly with dementia-related agitation.
    Pratt CE; Davis SM
    Ann Pharmacother; 2002 Oct; 36(10):1625-8. PubMed ID: 12243614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled study of divalproex sodium for agitation in dementia.
    Porsteinsson AP; Tariot PN; Erb R; Cox C; Smith E; Jakimovich L; Noviasky J; Kowalski N; Holt CJ; Irvine C
    Am J Geriatr Psychiatry; 2001; 9(1):58-66. PubMed ID: 11156753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic.
    Narayan M; Nelson JC
    J Clin Psychiatry; 1997 Aug; 58(8):351-4. PubMed ID: 9515973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
    Tariot PN; Raman R; Jakimovich L; Schneider L; Porsteinsson A; Thomas R; Mintzer J; Brenner R; Schafer K; Thal L; ;
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):942-9. PubMed ID: 16286437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open trial of valproate for agitation in geriatric neuropsychiatric disorders.
    Porsteinsson AP; Tariot PN; Erb R; Gaile S
    Am J Geriatr Psychiatry; 1997; 5(4):344-51. PubMed ID: 9363292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate use in neuropsychiatric disorders in the elderly.
    Tariot PN
    Psychopharmacol Bull; 2003; 37 Suppl 2():116-28. PubMed ID: 15021866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances.
    Kunik ME; Puryear L; Orengo CA; Molinari V; Workman RH
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):29-34. PubMed ID: 9489578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.
    Puryear LJ; Kunik ME; Workman R
    J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):234-7. PubMed ID: 8561838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex: a possible treatment alternative for demented, elderly aggressive patients.
    Haas S; Vincent K; Holt J; Lippmann S
    Ann Clin Psychiatry; 1997 Sep; 9(3):145-7. PubMed ID: 9339879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions.
    Wassef AA; Winkler DE; Roache AL; Abobo VB; Lopez LM; Averill JP; Mian AI; Overall JE
    Am J Psychiatry; 2005 Feb; 162(2):330-9. PubMed ID: 15677599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study.
    Zarate CA; Tohen M; Narendran R; Tomassini EC; McDonald J; Sederer M; Madrid AR
    J Clin Psychiatry; 1999 Apr; 60(4):232-6. PubMed ID: 10221283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of behavioural and psychological symptoms of dementia in psychogeriatric inpatient units.
    Restifo S; Lemon V; Waters F
    Australas Psychiatry; 2011 Feb; 19(1):59-63. PubMed ID: 21189108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Mucke HA; Krüger-Rainer C; Haushofer M; Kasper S
    CNS Drugs; 2004; 18(1):49-55. PubMed ID: 14731059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.